Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.

Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses ...

Our fair value estimate is 8.2% lower than Novavax's analyst price target of US$16.43 How far off is Novavax, Inc. (NASDAQ:NVAX) from its intrinsic value? Using the most recent financial data, we'll ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

Third annual conference convened Canada-connected individuals from across Asia and Asia-engagers from Canada over two days in ...

The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw ...

Meanwhile, the number of Coronavirus patients admitted to hospitals is also rising significantly. For every 100,000 people in Berlin, 11.2 were recently hospitalized with Covid-19, compared to 3.8 a ...